100Unicorns, one of India's leading early-stage venture capital funds, today announced a successful exit from TruNativ, delivering an approximate 11x return on invested capital since 2021.
100Unicorns was amongst the first to invest in TruNativ, betting early on rising Indian consumer demand for clean-label, science-backed nutrition products.
Nikhil Kamath-backed Rainmatter and FMCG giant Emami invested in subsequent rounds, a signal that validated the fund’s early conviction in the category.
TruNativ has built a strong portfolio of nutrition products across categories, expanding through both digital and omnichannel distribution to become one of the leading brands in India’s health and wellness space.
Valued at around $29–30 billion in 2024, it is projected to reach $37–38 billion by 2026 and $55–57 billion by 2030, growing at a CAGR of approximately 10.5%, according to a report from CareEdge Ratings.
